Related Experiment Video
Updated: Aug 23, 2026
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
Published on: June 7, 2015
Implanted gold markers for position verification during irradiation of head-and-neck cancers: a feasibility study
Bram van Asselen1, Homan Dehnad, Cornelis P J Raaijmakers
1Department of Radiotherapy, University Medical Center Utrecht, Utrecht, The Netherlands.
Purpose:
To assess the toxicity and reliability of the use of implanted gold markers for position verification during irradiation of head-and-neck cancer.
Methods And Materials:
Ten patients with localized head-and-neck tumors received two gold markers in the parapharyngeal region. The acute and late radiation-related toxicity were scored prospectively using the Common Toxicity Criteria. The patients were immobilized during irradiation using a five-point mask. The marker location was detected in portal images taken with an a-Si flat panel imager. The intermarker distance, as well as the interfraction motion of the markers, was determined for all patients.
Results:
No acute major complications were observed. The acute toxicity grade was not greater than normally detected. The markers were visible in all images. On average, the projected intermarker distance varied 0.8 mm (1 standard deviation). A small time trend was observed in the intermarker distance for 3 patients. For these patients, at least one marker was located in the mucosa or pharyngeal constrictor muscle. Deeper-seated gold markers did not show a time trend in the intermarker distance. The random positioning uncertainty determined using the markers was on average 1.1 and 1.4 mm (1 SD) in the craniocaudal and AP direction, respectively.
Conclusion:
The use of implanted gold markers for position verification during radiotherapy for head-and-neck cancer patients seems safe and feasible. To avoid any chance of migration, markers should be placed in deep muscular compartments.
